Federal Court Judge Weighing Four Factors In Plavix Preliminary Injunction Hearing
This article was originally published in The Pink Sheet Daily
Federal Judge Sidney Stein said he will weigh four factors to determine whether to issue a preliminary injunction in favor of Sanofi-Aventis and Bristol-Myers Squibb blocking sales of generic clopidogrel by Apotex
You may also be interested in...
During an Aug. 18 hearing, Apotex says a preliminary injunction should not include a recall of generic clopidogrel.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.